ONC Q3 2020 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q3 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$91M+81.6% YoY

Gross Profit

$70M76.8% margin

Operating Income

-$440M-483.2% margin

Net Income

-$425M-466.9% margin

EPS (Diluted)

$-4.81

QoQ Revenue Growth

+38.8%

Cash Flow

Operating Cash Flow

-$346M

Free Cash Flow

-$421M

Stock-Based Comp.

$50M

Balance Sheet

Total Assets

$5.6B

Total Liabilities

$1.3B

Stockholders' Equity

$4.3B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91M	$50M	+81.6%
Gross Profit	$70M	-$207M	+133.8%
Operating Income	-$440M	-$312M	-40.9%
Net Income	-$425M	-$307M	-38.3%